Oncternal Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2014 to Q3 2024.
  • Oncternal Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 2.96M shares, a 0.41% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2.94M shares, a 11.8% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.63M shares, a 94.7% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 49.3M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 2.96M +12K +0.41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 2.96M +24K +0.82% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 2.96M +33K +1.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2.94M +310K +11.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 2.95M -51.3M -94.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 2.94M -47.1M -94.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 2.93M -46.5M -94.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 2.63M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 54.2M +4.82M +9.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 50.1M +700K +1.42% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 49.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 49.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 49.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q4 2017 21.5M +5.83M +37.1% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-13
Q3 2017 16.1M +1.93M +13.6% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-13
Q2 2017 16M +1.87M +13.2% Apr 1, 2017 Jun 30, 2017 10-K 2018-03-13
Q1 2017 16M +1.87M +13.2% Jan 1, 2017 Mar 31, 2017 10-K 2018-03-13
Q4 2016 15.7M +1.68M +11.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 14.2M +152K +1.08% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 14.2M +138K +0.98% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 14.2M +119K +0.85% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 14M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 14M -62M -81.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 14M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 14M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q3 2014 76M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.